Piraeus Medical
Maple Grove, US · Founded 2021 · Delaware corporation
Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
Founders & leadership
Board
RE
Ryan EgelandBoard director
MO
Martin Omid AkhavanBoard director
Reported raises · per SEC filings
Form D private placements$14.1M disclosed across 10 rounds · 2022–2026
▶$3.6MraisedApr 2026 · 11 investors · Other Health CareRule 506(b)
▶$3.6MraisedApr 2026 · 11 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Martin Omid AkhavanDirector
- Jared HutarExecutive Officer, Director
- Ryan EgelandDirector
- Keith KallmesDirector
- Kevin KallmesDirector
- Offering amount
- $10.5M
- Amount sold
- $3.6M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$662.6KraisedNov 2025 · 4 investors · Other Health CareRule 506(b)
▶$662.6KraisedNov 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan EgelandDirector
- Keith KallmesDirector
- Martin AkhavanDirector
- Kevin KallmesDirector
- Jared HutarExecutive Officer, Director
- Offering amount
- $2.2M
- Amount sold
- $662.6K
- Minimum investment
- $1K
- First sale
- Oct 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$300KraisedSep 2025 · 1 investors · Other Health CareRule 506(b)
▶$300KraisedSep 2025 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ryan EgelandDirector
- Jared HutarExecutive Officer, Director
- Keith KallmesDirector
- Kevin KallmesDirector
- Martin Omid AkhavanDirector
- Offering amount
- $300K
- Amount sold
- $300K
- Minimum investment
- $1
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2MraisedFeb 2025 · 65 investors · Other Health CareRule 506(b)
▶$2MraisedFeb 2025 · 65 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer, Director
- Martin Omid AkhavanDirector
- Ryan EgelandDirector
- Keith KallmesDirector
- Kevin KallmesDirector
- Offering amount
- $2M
- Amount sold
- $2M
- Minimum investment
- $500
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6MraisedJul 2024 · 79 investors · Other Health CareRule 506(b)
▶$6MraisedJul 2024 · 79 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer, Director
- Keith KallmesDirector
- Kevin KallmesDirector
- Ryan EgelandDirector
- Martin Omid AkhavanDirector
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $25K
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$450KraisedApr 2024 · 5 investors · Other Health CareRule 506(b)
▶$450KraisedApr 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jared HutarExecutive Officer
- Kevin KallmesDirector
- Keith KallmesDirector
- Offering amount
- $3.5M
- Amount sold
- $450K
- Minimum investment
- $5K
- Proceeds to insiders
- $150K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$3.1KraisedAug 2023 · 2 investors · Other Health CareRule 506(b)
▶$3.1KraisedAug 2023 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Kevin KallmesDirector
- Keith KallmesDirector
- Jared HutarExecutive Officer
- Offering amount
- $3.1K
- Amount sold
- $3.1K
- Minimum investment
- $1
- First sale
- Aug 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$150KraisedDec 2022 · 2 investors · Other Health CareRule 506(b)
▶$150KraisedDec 2022 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Keith KallmesExecutive Officer, Director
- Jared HutarExecutive Officer
- Keith KallmesExecutive Officer, Director
- Offering amount
- $3.5M
- Amount sold
- $150K
- Minimum investment
- $1K
- Proceeds to insiders
- $200K
- First sale
- Dec 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 4
by search overlapBoston Scientific7 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Read the Press Release6 shared keywordsStryker is a medical technology company that develops and manufactures products across areas such as orthopaedics, surgical equipment, neurotechnology, and spine care for hospitals and healthcare providers. It operates globally across the Americas, Europe, Asia-Pacific, and the Middle East.
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Inquis Medical5 shared keywordsInquis Medical is a medical device company developing minimally invasive technology to treat thromboembolic disease in the cardiovascular and vascular space. The company is led by a team of medtech entrepreneurs and physicians with experience in endovascular and interventional cardiology devices.
Companies competing with Piraeus Medical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Piraeus Medical do?
- Piraeus Medical develops catheters built with a patented linerless construction, including the NeuGlide+ (0.087" inner diameter, compatible with a 7F introducer sheath) and NeuFlex (0.093" inner diameter, compatible with an 8F introducer sheath). It operates in the medical device sector.
- How much funding has Piraeus Medical raised?
- Piraeus Medical has disclosed $14.1M raised across 10 rounds.
- Where is Piraeus Medical headquartered?
- Piraeus Medical is headquartered in Maple Grove, US.

